Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Merck & Co. and Hanmi Pharmaceutical, a Seoul, South Korea-based pharmaceutical company, have formed an exclusive licensing agreement, in a deal worth up to $870 million, for the development, manufacture and commercialization of efinopegdutide,...

Elanco Animal Health, the former animal-health business of Eli Lilly and Company and now a stand-alone company, has closed its $6.89-billion acquisition of Bayer Animal Health. The companies signed an agreement for the acquisition in August 2019....

The US government, through the US International Development Finance Corporation (DFC), has signed a letter of interest to provide a $765-million loan to Eastman Kodak Company to support the launch of Kodak Pharmaceuticals, a new arm of the company...

GlaxoSmithKline (GSK) and CureVac, a Tubingen, Germany-based clinical-stage biopharmaceutical company developing a messenger ribonucleic acid (mRNA) therapeutics, have signed a strategic collaboration agreement, in a deal worth up to £866 million...

A roundup of news from Switzerland (BI, Numab Therapeutics) and the US (Bayer, Elanco, Mylan, Merck & Co, Dewpoint Therapeutics, and Nephron Pharmaceuticals). Switzerland BI, Numab Therapeutics in Pact for Antibody Therapies for Cancer,...

Roche and Blueprint Medicines, a Cambridge, Massachusetts-based biopharmaceutical company, have signed a licensing and collaboration agreement, in a deal worth up to $1.7 billion, to develop and commercialize pralsetinib, an investigational oral...